Cargando…
Validation of Serum Biomarkers That Complement CA19-9 in Detecting Early Pancreatic Cancer Using Electrochemiluminescent-Based Multiplex Immunoassays
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy; its early detection is critical for improving prognosis. Electrochemiluminescent-based multiplex immunoassays were developed with high analytical performance. All proteins were analyzed in sera of patients diagnosed with PDAC (n = 138),...
Autores principales: | Song, Jin, Sokoll, Lori J., Chan, Daniel W., Zhang, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698985/ https://www.ncbi.nlm.nih.gov/pubmed/34944713 http://dx.doi.org/10.3390/biomedicines9121897 |
Ejemplares similares
-
A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma
por: Song, Jin, et al.
Publicado: (2019) -
VCAM-1 complements CA-125 in detecting recurrent ovarian cancer
por: Song, Jin, et al.
Publicado: (2023) -
Development and validation of a multiplex electrochemiluminescence immunoassay to evaluate dry eye disease in rat tear fluids
por: Compagnone, Agnese, et al.
Publicado: (2023) -
Comparison of Bead-Based Fluorescence Versus Planar Electrochemiluminescence Multiplex Immunoassays for Measuring Cytokines in Human Plasma
por: Günther, Anna, et al.
Publicado: (2020) -
Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer
por: Dong, Dong, et al.
Publicado: (2018)